OV’s method can predict if neoadjuvant treatment with doxorubicin in breast cancer will be successful, data published in ASCO journal

David Linetsky
Point-of-Care Marketing

Pat Purcell
Meeting Engagement

Frank Burrell
Scientific Storytelling

Brenda Snow
Authentic Patient Voice

Matthew Durham
Omnidynamic Marketing

Joey Cohen
Medication Adherence

Liz Kane
Impactful Strategy

Stacey Gandler
Brand Nourishment

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access